InvestorsObserver
×
News Home

Should You Hold Titan Pharmaceuticals, Inc. common stock (TTNP) Stock Friday Morning?

Friday, July 22, 2022 08:35 AM | InvestorsObserver Analysts

Mentioned in this article

Should You Hold Titan Pharmaceuticals, Inc. common stock (TTNP) Stock Friday Morning?

Titan Pharmaceuticals, Inc. common stock (TTNP) is down -2.19%% today.

Overall Score - 55
TTNP has an Overall Score of 55. Find out what this means to you and get the rest of the rankings on TTNP!
TTNP stock closed at $1.37 and is down -$0.03 during pre-market trading. Pre-market tends to be more volatile due to significantly lower volume as most investors only trade between standard trading hours. TTNP has a roughly average overall score of 55 meaning the stock holds a better value than 55% of stocks at its current price. InvestorsObserver's overall ranking system is a comprehensive evaluation and considers both technical and fundamental factors when evaluating a stock. The overall score is a great starting point for investors that are beginning to evaluate a stock. TTNP gets a average Short-Term Technical score of 60 from InvestorsObserver's proprietary ranking system. This means that the stock's trading pattern over the last month have been neutral. Titan Pharmaceuticals, Inc. common stock currently has the 76th highest Short-Term Technical score in the Biotechnology industry. The Short-Term Technical score evaluates a stock's trading pattern over the past month and is most useful to short-term stock and option traders.
Titan Pharmaceuticals, Inc. common stock's Overall and Short-Term Technical score paint a mixed picture for TTNP's recent trading patterns and forecasted price. Click Here To Get The Full Report on Titan Pharmaceuticals, Inc. common stock (TTNP)

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App